Literature DB >> 10912598

Scleroderma in childhood: a 35-year history of cases and review of the literature.

C R Bottoni1, K A Reinker, R D Gardner, D A Person.   

Abstract

Scleroderma is a connective tissue disease with a variety of clinical presentations. The purpose of our study was to review representative cases of scleroderma in childhood to determine the initial presentation, course of the disease, orthopaedic manifestations, and the necessity and success of surgical intervention. Records from the four medical centers were retrospectively reviewed to identify the patients who were diagnosed with scleroderma over the past 35 years. Data on disease presentation, course, treatment, and response were collected. Seventeen cases representing the variety of clinical presentations are presented. Scleroderma characteristically presents with asymmetric lesions involving the extremities and remains a diagnostic and therapeutic challenge. Treatment must be individualized to the patient and his or her specific limitations brought about by the disease. Early diagnosis, supportive care, and physical therapy combined with early orthopaedic surgical intervention to release joint contractures are among the most efficacious treatments.

Entities:  

Mesh:

Year:  2000        PMID: 10912598

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  3 in total

1.  Frequency of antinuclear antibodies in mestizo Mexican children with morphea.

Authors:  Elizabeth Guevara-Gutiérrez; Janeth Yinh-Lao; Patricia García-Gutiérrez; Alberto Tlacuilo-Parra
Journal:  Clin Rheumatol       Date:  2010-06-14       Impact factor: 2.980

2.  Juvenile linear scleroderma with unique forms of renal involvement.

Authors:  Belde Kasap; Alper Soylu; Mehmet Türkmen; Yiğit Göktay; Sülen Sarioğlu; Can Oztürk; Ozgür Kasapçopur; Salih Kavukcu
Journal:  Pediatr Nephrol       Date:  2009-05-28       Impact factor: 3.714

Review 3.  Approach to a patient with connective tissue disease.

Authors:  T Sathish Kumar; Amita Aggarwal
Journal:  Indian J Pediatr       Date:  2010-10-06       Impact factor: 5.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.